Shares of Advanced Micro Devices (AMD) surged nearly 9% on Monday, positioning the semiconductor giant as a leading performer among S&P 500 stocks. This significant […]
Biotech firm Sarepta Therapeutics has announced a significant pause in its clinical trial and distribution protocols for Elevidys (SRP-9001), its approved gene therapy targeting Duchenne […]
Costco Takes Bold Step with First Standalone Gas Station Warehouse retail giant Costco is making a significant move into the fuel market with plans for […]
US stock markets saw broad gains today, with the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all closing higher. This upward movement occurred […]
The Trump brand is expanding its reach, this time entering the competitive landscape of the U.S. telecommunications market. On June 16, 2025 – exactly 10 […]
Sarepta Halts Elevidys for Non-Ambulatory Duchenne Patients After Second Death Sarepta Therapeutics is halting shipments of its Duchenne muscular dystrophy gene therapy, Elevidys, for patients […]
Sarepta and Roche Pause Gene Therapy Use Following Patient Deaths Sarepta Therapeutics and its global partner Roche have announced the immediate halting of commercial and […]
